Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe De Wals

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 10, 2010
Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programsPhilippe De Wals, Nicole Boulianne, Elodie Sévin, et al.
Public Health Nutrition|September 24, 2019
Pattern and correlates of public support for public health interventions to reduce the consumption of sugar-sweetened beveragesAriane Bélanger-Gravel, Sophie Desroches, Isidora Janezic, et al.
Vaccine|May 19, 2009
Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutionsPhilippe De Wals, Geneviève Deceuninck, Manale Ouakki, et al.
The Pediatric Infectious Disease Journal|October 11, 2008
Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, CanadaPhilippe De Wals, Elodie Robin, Elise Fortin, et al.
Vaccine|March 5, 2010
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterMarc Brisson, Gurgen Melkonyan, Melanie Drolet, et al.
BMC Infectious Diseases|April 20, 2007
Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003Magalie Canuel, Gaston De Serres, Bernard Duval, et al.
Vaccine|October 10, 2013
Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic modelDavid M Vickers, Andrea M Anonychuk, Philippe De Wals, et al.
Vaccine|October 26, 2002
Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more doseBernard Duval, Nicole Boulianne, Gaston De Serres, et al.
International Journal of Pediatric Otorhinolaryngology|May 9, 2009
New vaccines offering a larger spectrum of protection against acute otitis media: will parents be willing to have their children immunized?Eve Dubé, Philippe De Wals, Vladimir Gilca, et al.
The Journal of Infection|April 26, 2024
Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complexRaymond S W Tsang, Genevieve Deceuninck, Courtney Meilleur, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 10, 2010
Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programsPhilippe De Wals, Nicole Boulianne, Elodie Sévin, et al.
Public Health Nutrition|September 24, 2019
Pattern and correlates of public support for public health interventions to reduce the consumption of sugar-sweetened beveragesAriane Bélanger-Gravel, Sophie Desroches, Isidora Janezic, et al.
Vaccine|May 19, 2009
Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutionsPhilippe De Wals, Geneviève Deceuninck, Manale Ouakki, et al.
The Pediatric Infectious Disease Journal|October 11, 2008
Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, CanadaPhilippe De Wals, Elodie Robin, Elise Fortin, et al.
Vaccine|March 5, 2010
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterMarc Brisson, Gurgen Melkonyan, Melanie Drolet, et al.
BMC Infectious Diseases|April 20, 2007
Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003Magalie Canuel, Gaston De Serres, Bernard Duval, et al.
Vaccine|October 10, 2013
Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic modelDavid M Vickers, Andrea M Anonychuk, Philippe De Wals, et al.
Vaccine|October 26, 2002
Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more doseBernard Duval, Nicole Boulianne, Gaston De Serres, et al.
International Journal of Pediatric Otorhinolaryngology|May 9, 2009
New vaccines offering a larger spectrum of protection against acute otitis media: will parents be willing to have their children immunized?Eve Dubé, Philippe De Wals, Vladimir Gilca, et al.
The Journal of Infection|April 26, 2024
Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complexRaymond S W Tsang, Genevieve Deceuninck, Courtney Meilleur, et al.
Pageof 13